Clean Air and Climate Change
This program on clean air and climate change examines these possible challenges and explores how they can be eliminated, mitigated and better understood.
Are Renewables an Energy Solution?
Continuing on in the energy series, we hear from panelists as they discuss renewable energy solutions and their viability as an alternative solution.
In the news once again: Goldman Sachs…
Goldman Sachs Director, Greg Smith, resigned and published a letter with the NY Times. Bill George was on a committee that examined sound business practices.
Bill George on Character and Leadership
During this episode on Character and Leadership, former Medtronic CEO, Bill George, now Professor of Management Practice at Harvard Business School, joins Dennis McCuistion for a frank discussion on ethics and business practices in corporate America.
Oil, Gas & Energy Security for America
Energy security is critical to our future. For the first time in a long time we should feel better about our long-term energy prospects. Join Laura Miller, Chuck Davidson and others as we discuss.
The Fallout of Problems in American Corporate Governance and Its Impact on China and the World
During this episode on corporate governance and its impact on China and the world, panelists discuss the credit crisis and changes in trade relationships between the United States and China.
“Buy Enron stock today!” A Tale of Two Cities…
"Buy Enron stock today!" These were Jeff Skilling’s ending words to the group of civic and business leaders assembled at Southern Methodist University in Dallas in 2001.
Is Corporate Ethics an Oxymoron?
Guests, Sharon Allen of Deloitte, Todd Bluedorn of Lennox Internationl and Jared Richardon of Energy Future Holdings discuss corporate ethics.
The Government’s Response to the Crisis In Corporate Governance
The federal government took many quick actions in the wake of the credit crisis in order to stop the damage. Now it wants to implement new regulations to prevent future problems. In this episode of McCuistion TV, we examine changes in corporate governance.
Prescription Drug Costs and Safety: Part Two
Although prescription drugs are not always needed to assist in the health of a patient, bureaucracy and corruption in the FDA prevent the correct treatment for many ailments.